Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06258148
What this trial is testing

TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 465
Testing effectiveness (Phase 2)Study completedNCT01822925
What this trial is testing

Study of DA-9801 to Treat Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathy
NeuroBo Pharmaceuticals Inc. 128
Post-approval studies (Phase 4)Study completedNCT00402909
What this trial is testing

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

Who this might be right for
Type 2 Diabetes
Novartis Pharmaceuticals 28
Large-scale testing (Phase 3)UnknownNCT04603508
What this trial is testing

Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

Who this might be right for
Type 2 Diabetes MellitusDyslipidemia
EMS 240
Post-approval studies (Phase 4)Study completedNCT01438814
What this trial is testing

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 689
Large-scale testing (Phase 3)Ended earlyNCT01481116
What this trial is testing

Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 2,454
Early research (Phase 1)Study completedNCT01811849
What this trial is testing

Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Biodel 12
Not applicableNot Yet RecruitingNCT06819371
What this trial is testing

Impact of Dual vs. Single Task Exercise on Cognitive Function, Balance, and Functionality in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Izmir Democracy University 36
Large-scale testing (Phase 3)Study completedNCT00396071
What this trial is testing

Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 22
Early research (Phase 1)Active Not RecruitingNCT07223333
What this trial is testing

PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Who this might be right for
Type 2 Diabetes
AdipoPharma LLC 56
Early research (Phase 1)Study completedNCT01511185
What this trial is testing

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 20
Testing effectiveness (Phase 2)Looking for participantsNCT07502508
What this trial is testing

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Who this might be right for
Type 2 Diabetes
Biomea Fusion Inc. 60
Post-approval studies (Phase 4)Study completedNCT03338855
What this trial is testing

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

Who this might be right for
Diabetes Mellitus, Type 2Skeletal Muscle Insulin Sensitivity
AstraZeneca 26
Early research (Phase 1)Study completedNCT00836225
What this trial is testing

Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 103
Large-scale testing (Phase 3)UnknownNCT03641352
What this trial is testing

The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

Who this might be right for
Type2 Diabetes
Chong Kun Dang Pharmaceutical 240
Large-scale testing (Phase 3)Study completedNCT01001611
What this trial is testing

An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 173
Early research (Phase 1)Study completedNCT05579314
What this trial is testing

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Sciwind Biosciences USA Co., Ltd. 127
Testing effectiveness (Phase 2)Study completedNCT01276106
What this trial is testing

Study of AC-201 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
TWi Biotechnology, Inc. 259
Large-scale testing (Phase 3)Study completedNCT00351884
What this trial is testing

Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 370
Early research (Phase 1)Study completedNCT01524809
What this trial is testing

Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 26
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation